ReviewFrontiers in pharmacology2025
Clinical characterization and management of persons with comorbid epilepsy and depression: an expert opinion paper.
Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Occurrence and clinical correlates of depressive symptoms in adults with epilepsy: A study in Georgia.Epilepsia open · 2026Article
- Epilepsy grand challenge 2025.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Medical conditions related to the nervous system affects 3.4 billion individuals worldwide and are collectively ranked as the leading cause of disability-adjusted life years (DALYs). Epilepsy is listed among the ten conditions with the highest age standardized DALYs, while depression is expected to become the first cause of disability for mental disorders by 2030. Persons with epilepsy have a higher risk of developing depression, and Methods: The present mini-review is based on expert meetings held in the period May-September 2024. A panel of expert clinicians, working in the field of epilepsy and of clinical psychiatry have been invited to participate, due to their experience and expertise in the topic. Panel members, under the guidance of two senior experts, have identified the relevant topics to be analyzed, discussed and commented. Results: Included studies dealt with the historical perspective on epilepsy and depression; the complexity of diagnostic and clinical comorbidity between epilepsy and depression; the assessment tools for screening for depression in patients with epilepsy. Discussion: The clinical condition of patients suffering from comorbid depression and epilepsy represents a challenge for neurologists and psychiatrists. Therefore, the management of comorbid epilepsy and depression requires a detailed clinical characterization of each individual case in order to develop an integrated and personalized management plan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.